Trials / Withdrawn
WithdrawnNCT00453414
Safety and Efficacy of Inhaled Iloprost in Pediatric Patients With Pulmonary Arterial Hypertension
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Actelion · Industry
- Sex
- All
- Age
- 3 Years – 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and effectiveness of iloprost for PAH in children who are between the ages of 3 and 18 years old.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Iloprost Inhalation Solution (Ventavis) |
Timeline
- Start date
- 2006-07-01
- Primary completion
- 2006-10-01
- Completion
- 2006-10-01
- First posted
- 2007-03-29
- Last updated
- 2010-02-15
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00453414. Inclusion in this directory is not an endorsement.